Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03535597 · ClinicalTrials.gov registry record · NA

Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access

A NA study of Coronary Artery Disease, sponsored by Memorial Healthcare System.

Completed
Registry status
NA
Development phase
355
Enrollment target
1
Study location

NCT03535597 is a NA study of Coronary Artery Disease that has completed, run by Memorial Healthcare System. The registered enrollment target is 355 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03535597, a NA study of Coronary Artery Disease, has completed, sponsored by Memorial Healthcare System.

COMPLETED
Registry status
NA
Development phase
355 participants
Enrollment target
1
Study location

Study Summary

To evaluate the efficacy and safety of the QuikClot® Radial® pad on hemostasis after transradial access (TRA), compared to the standard of care TR Band®, to hopefully develop a safe and efficacious technique to achieve more rapid patent hemostasis after TRA, and improve patient care by optimizing radial hemostasis management.

Conditions Studied

Interventions

  • DEVICE Quikclot Radial (QC) Pad

Study Locations (1)

Florida

  • Memorial Healthcare System - Hollywood

Trial Details

FieldValue
Enrollment Target 355 participants
Start Date 2018-08-01
Est. Completion 2022-12-28
Phase NA

Sponsor

Memorial Healthcare System

7 total trials

What the Registry Record Tells You About NCT03535597

The ClinicalTrials.gov registry entry for NCT03535597 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 355 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (72% lower). The listed sponsor is Memorial Healthcare System, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Quikclot Radial (QC) Pad is the first listed.

NCT03535597 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03535597 about?

NCT03535597 is a clinical study titled "Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access". To evaluate the efficacy and safety of the QuikClot® Radial® pad on hemostasis after transradial access (TRA), compared to the standard of care TR Band®, to hopefully develop a safe and efficacious technique to achieve more rapid patent hemostasis after TRA, and improve patient care by optimizing ra...

What is the current status of trial NCT03535597?

This trial is currently completed. It is a NA study. The enrollment target is 355 participants. The study started on 2018-08-01. Estimated completion is 2022-12-28.

What conditions does trial NCT03535597 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT03535597?

The interventions under investigation include: Quikclot Radial (QC) Pad (DEVICE).

Who is sponsoring clinical trial NCT03535597?

This trial is sponsored by Memorial Healthcare System, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03535597 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.